Mounjaro Wholesale Price: What It Means and What You'll Actually Pay

What the Eli Lilly price rise tells us about tirzepatide wholesale pricing in the UK

Wholesale drug pricing is the rate agreed between a manufacturer and the licensed supply chain, the distributors and pharmacies authorised to handle the product. For Mounjaro, that baseline shifted sharply in late 2025 when Eli Lilly revised its UK list price upward, with the highest-dose pen moving from roughly £122 to around £330 in a single adjustment. That change rippled through the entire private market, and it explains why the Mounjaro price increase felt sudden to many patients who were already on treatment.

NICE's appraisal of tirzepatide, published as TA1026 in December 2024, recommended tirzepatide for NHS use within a phased rollout, but NHS pricing is negotiated separately from the list price and is not published. The figure that shapes private costs is the commercial list price, and understanding that the wholesale rate is only the floor helps explain why two providers can charge very different amounts for the same pen.

For a detailed breakdown of how current private prices compare across doses, the Mounjaro private price guide sets out what the market looks like today. The short version: dose matters a great deal. The 2.5mg starter pen sits at the lower end of the range; by the time a patient reaches the higher maintenance doses, the monthly cost looks quite different. If you want to understand where the mid-range doses sit, our page covering what the 5mg Mounjaro pen currently costs shows how that figure compares to the doses on either side of it.

What headline prices from online providers typically leave out

A quoted monthly figure for Mounjaro often covers the pen and little else. The items most commonly excluded from a headline price include the initial consultation fee, the prescription charge, delivery costs, and any ongoing clinical monitoring between doses. Add those together and a price that looked competitive at first glance can end up costing more in practice.

There is also the question of what happens if your dose needs reviewing, if you have a question between orders, or if you want to move from one strength to the next. Some providers charge separately for each of those touchpoints. Others bundle aftercare into a subscription model that auto-renews whether you want it to or not. Neither is necessarily dishonest, but neither is transparent in the way that a single, all-in figure is transparent.

At nume, one price covers the consultation, the prescription, the treatment itself, and free next-working-day delivery. Your pen arrives in a plain box via DPD (you get a tracking link the moment it leaves our GPhC-registered pharmacy) and there is nothing extra to pay when it does. We do not run subscriptions. Every repeat order is re-reviewed by a prescriber before it is dispensed. That is the model; the current treatment pricing is shown on the consultation page rather than here, because what you pay depends on the dose a prescriber decides is right for you.

Why 'cheapest' is the wrong question for a prescription medicine

There is a version of the tirzepatide wholesale price question that is really asking: where can I get this for as little as possible? The honest answer is that the cheapest listing for a prescription-only medicine is not a bargain, it is a signal worth scrutinising. The MHRA has warned repeatedly about fake weight-loss pens sold online, and enforcement through 2025 led to the seizure of roughly 20 million doses of illegally traded weight-loss medicines (worth around £45m), including the first UK raid on a site producing counterfeit tirzepatide pens. Those products bypassed the licensed supply chain entirely. The price was low because the product was not genuine.

Verifying that a pharmacy is legitimate takes thirty seconds: the GPhC pharmacy register is public. Any pharmacy that cannot be found there should not be supplying prescription medicines. Sellers offering Mounjaro without a clinical assessment or at prices far below the current market range are a red flag regardless of what they claim about their sourcing. Report any suspect seller through the MHRA Yellow Card scheme.

The right measure for a prescription medicine is not the lowest price. It is whether the supply chain is licensed, whether a real clinician has assessed whether treatment is appropriate for you, and whether someone is monitoring your progress. At nume, our prescribers (you can read about our clinical team on the clinical oversight page) review every consultation personally, the same day. We are deliberately not the cheapest option on the market. That is a choice. For a full picture of how dose and price interact across the Mounjaro range, our guide to Mounjaro pen pricing covers how each strength is currently priced, and the tirzepatide price comparison page lays it out clearly.